top of page

Frontiers Topic Open for Submissions - Enzymes in Brain Trauma and Disease

Frontiers is the 3rd most-cited research publisher and reports groundbreaking discoveries by the world's top experts. Frontiers, Experimental Therapeutics is now accepting submissions that highlight the roles of enzymes in neurological injury or disease. Authors are also encouraged to submit relevant work describing enzymes associated with infectious agents, e.g. SARS-CoV-2, as applicable to neurological symptoms and / or damage.

Visit Frontiers to learn more

To learn how we can assist with your needs within science and medicine, visit Aries Biotech at

26 views0 comments

Recent Posts

See All

Thank you - Alzheimer’s Research UK!

Aries Biotech extends gratitude to the Alzheimer’s Research UK team, for inviting Dr. Angela Boutte, the founder of Aries Biotech, as a contributing reviewer and panelist. Through partnerships with th


bottom of page